---
title: "RemeGen Expects 2025 Net Profit to Reach RMB716 Million on 89% Revenue Surge"
description: "RemeGen Co. Ltd. expects a net profit of RMB716 million for 2025, driven by an 89% revenue surge. The company attributes this improvement to a better cost structure, enhanced gross profit margins, and"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/274301011.md"
published_at: "2026-01-30T11:37:31.000Z"
---

# RemeGen Expects 2025 Net Profit to Reach RMB716 Million on 89% Revenue Surge

> RemeGen Co. Ltd. expects a net profit of RMB716 million for 2025, driven by an 89% revenue surge. The company attributes this improvement to a better cost structure, enhanced gross profit margins, and reduced sales expenses. Excluding non-recurring items, RemeGen anticipates a turnaround in net profit for the year, reflecting significant business performance enhancement. These figures are preliminary estimates and highlight the company's positive trajectory.

RemeGen Co. Ltd. has announced its estimated annual results for the year ended December 31, 2025. The company expects a substantial improvement in profitability efficiency for the period, with a significant turnaround in net profit compared to previous years. This positive shift is attributed to increased revenue, optimized cost structure, improved gross profit margins, and a marked reduction in the sales expense ratio. Additionally, after excluding non-recurring gains and losses, the company anticipates achieving a turnaround in net profit attributable to owners of the parent company for 2025. The disclosed figures are based on preliminary estimates and reflect a notable enhancement in RemeGen’s business performance for the year. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RemeGen Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260130-12006496), on January 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [688331.CN - RemeGen](https://longbridge.com/en/quote/688331.CN.md)
- [09995.HK - REMEGEN](https://longbridge.com/en/quote/09995.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 榮昌生物提高了股票回購的價格上限 | 榮昌生物解除股票回購價格上限 | [Link](https://longbridge.com/en/news/272783447.md) |
| 交銀國際控股公司維持對榮昌生物有限公司 H 股（9995）的買入評級 | 在昨天發佈的一份報告中，交通銀行國際控股公司對榮昌生物（RemeGen Co. Ltd. Class H）維持了買入評級，目標價為 136.00 港元。聲明：享受 50% 的 TipRanks Premium 折扣，解鎖對沖基金級別的數據和 | [Link](https://longbridge.com/en/news/273178637.md) |
| 川普宣佈派醫療船赴格陵蘭 | 美國總統川普宣佈派遣一艘醫療船前往格陵蘭，稱該地對美國及北約在應對俄羅斯與中國方面的安全至關重要。川普表示這艘船將幫助格陵蘭的「生病的人」，但未透露具體情況。此舉加劇了美國與丹麥的緊張關係，並引發全球對北極地區的關注。川普在社交媒體上發布了 | [Link](https://longbridge.com/en/news/276537732.md) |
| 【黃金收評】川普對伊朗下最後通牒！金價醖釀下一波大行情 接下來如何交易？ | 週四現貨黃金收盤上漲 0.37%，報 4995.77 美元/盎司，受地緣政治風險支撐，但強勢美元和美聯儲鷹派立場限制漲幅。川普警告伊朗必須在 10 至 15 天內達成核協議，否則將面臨嚴重後果。美軍在該地區集結兵力，金價在過去兩日累計上漲超 | [Link](https://longbridge.com/en/news/276498546.md) |
| 中國白銀集團 (0815) 折讓 18% 配股籌 4.6 億 | 中國白銀集團宣佈將向 6 名認購人發行 9.1 億股認購股份，折讓約 17.74%，每股認購價為 0.51 元，籌集資金總額為 4.641 億元。所得款項將用於日喀則礦的資本開支、進一步融資及一般營運資金。 | [Link](https://longbridge.com/en/news/276432450.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.